tiprankstipranks

Mark Neumann Insider Profile

4 Followers
Mark Neumann, EVP & CCO at Intra-Cellular Therapies, holds 29.70K shares in Intra-Cellular Therapies (Ticker: ITCI).
tipranks
Mark Neumann

Mark Neumann
Intra-Cellular Therapies (ITCI)
EVP & CCO

Ranked #81,994 out of 99,635 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-34.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of Mark Neumann's holdings

Insider Roles

Intra-Cellular Therapies
(ITCI)
EVP & CCO
Roles that Mark Neumann holds in companies

Most Profitable Insider Trade

Stock:
Intra-Cellular Therapies
(ITCI)
Rating:Informative Sell
Date:Aug 20, 2024 - Today
Return:-11.30%
The most profitable trade made by Mark Neumann

Mark Neumann's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intra-Cellular Therapies
Aug 20, 2024
EVP & CCO
Uninformative Buy
690.36K
$2.52M
Success Rate for
ITCI
0 out of 3 profitable transactions on
ITCI
0%
Average Return for
ITCI
Average return per transaction on
ITCI
-34.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 17, 2019
Uninformative Buy
$54.89K
-
$8.23
Jan 10, 2020
Uninformative Buy
$551.74K
-
$26.34
Oct 16, 2020
Uninformative Buy
$178.71K
-
$26.83
Jan 12, 2021
Uninformative Buy
$371.15K
-
$32.65
Feb 22, 2021
Uninformative Buy
$232.36K
-
$39.08
List of latest transactions for each holding click on a transaction to see Mark Neumann's performance on stock

Mark Neumann insider profile FAQ

What is the percentage of profitable transactions made by Mark Neumann?
The percentage of profitable transactions made by Mark Neumann is 0%.
    What is the average return per transaction made by Mark Neumann?
    The average return per transaction made by Mark Neumann is -34.50%.
      What stocks does Mark Neumann hold?
      Mark Neumann holds: ITCI stocks.
        What was Mark Neumann’s latest transaction?
        Mark Neumann latest transaction was an Uninformative Buy of $690.36K.
          What was Mark Neumann's most profitable transaction?
          Mark Neumann’s most profitable transaction was an Informative Sell of ITCI stock on August 20, 2024. The return on the trade was -11.30%.
            What is Mark Neumann's role in Intra-Cellular Therapies?
            Mark Neumann's role in Intra-Cellular Therapies is EVP & CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.